Skip to content

The rapeutic efficacy prediction of SUI by multi-modal signals: a prospective study

Key techniques for therapeutic efficacy prediction of stress urinary incontinence driven by multi-modal signals: a prospective study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096732
Enrollment
Unknown
Registered
2025-02-05
Start date
2025-01-05
Completion date
Unknown
Last updated
2025-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stress urinary incontinence

Interventions

Home Treatment Group:NA
In hospital treatment group:NA

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. stress urinary incontinence or mixed urinary incontinences as the chief complaint; 2. Adult female;

Exclusion criteria

Exclusion criteria: 1. Only urge urinary incontinence was present; 2. Pelvic organ prolapse above grade II (hymen bulge > 1cm); 3. Women who plan to become pregnant, are currently pregnant, and within 6 weeks postpartum; 4. Patients with spillage incontinence due to outlet tract obstruction; 5. Patients with urinary incontinence due to an ectopic urethra such as a urinary fistula; 6. The perineum was torn above degree III; 7. Patients with damage or inflammation in the perineal region, urinary system, vagina, anorectum; 8. History of pelvic floor surgery; 9. Malignant tumor of the pelvis; 10. Pelvic floor muscle training under formal training was performed within the past 5 years; 11. Pacemaker carriers or patients with other major diseases were not eligible for clinical trial, including coagulation disorders, severe heart, liver and kidney failure; Patients with severe upper urinary tract obstruction, pelvic floor peripheral nerve conduction obstruction; 12. Other factors affecting trial participation included frequent travel; Mental illness; The placement of a manometry device in the vagina was refused;

Design outcomes

Primary

MeasureTime frame
ICIQ-UI-SF;

Secondary

MeasureTime frame
POP-SS;IIQ-7;PISQ-12;BPMSES;ICIQ-B;PHQ-9;POP-Q;Modified Oxford scale;MVCP;Surface and intrapelvic EMG;Three dimensional body shape;Anatomy of the pelvic floor;microbiomics;proteomics;metabolomics;

Countries

China

Contacts

Public ContactZhijing Sun

Peking Union Medical College Hospital

sunzhj2001@sina.com+86 10 69156204

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026